TARS vs. APO
Compare and contrast key facts about Tarsus Pharmaceuticals, Inc. (TARS) and Apollo Global Management, Inc. (APO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TARS or APO.
Correlation
The correlation between TARS and APO is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TARS vs. APO - Performance Comparison
Loading data...
Key characteristics
TARS:
0.14
APO:
0.78
TARS:
0.96
APO:
1.21
TARS:
1.11
APO:
1.17
TARS:
0.39
APO:
0.80
TARS:
1.17
APO:
2.36
TARS:
18.64%
APO:
13.18%
TARS:
56.14%
APO:
44.19%
TARS:
-77.67%
APO:
-56.98%
TARS:
-27.19%
APO:
-18.55%
Fundamentals
TARS:
$1.86B
APO:
$81.98B
TARS:
-$2.70
APO:
$7.33
TARS:
7.95
APO:
3.36
TARS:
5.42
APO:
4.95
TARS:
$233.67M
APO:
$24.62B
TARS:
$217.29M
APO:
$22.44B
TARS:
-$98.27M
APO:
$7.81B
Returns By Period
In the year-to-date period, TARS achieves a -25.12% return, which is significantly lower than APO's -11.91% return.
TARS
-25.12%
-10.70%
-12.84%
8.05%
N/A
N/A
APO
-11.91%
15.21%
-10.90%
33.99%
31.90%
26.78%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TARS vs. APO — Risk-Adjusted Performance Rank
TARS
APO
TARS vs. APO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Apollo Global Management, Inc. (APO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TARS vs. APO - Dividend Comparison
TARS has not paid dividends to shareholders, while APO's dividend yield for the trailing twelve months is around 1.28%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
APO Apollo Global Management, Inc. | 1.28% | 1.10% | 1.81% | 2.51% | 2.90% | 4.72% | 4.23% | 7.86% | 5.53% | 6.46% | 12.91% | 13.19% |
Drawdowns
TARS vs. APO - Drawdown Comparison
The maximum TARS drawdown since its inception was -77.67%, which is greater than APO's maximum drawdown of -56.98%. Use the drawdown chart below to compare losses from any high point for TARS and APO. For additional features, visit the drawdowns tool.
Loading data...
Volatility
TARS vs. APO - Volatility Comparison
Tarsus Pharmaceuticals, Inc. (TARS) and Apollo Global Management, Inc. (APO) have volatilities of 13.24% and 13.56%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TARS vs. APO - Financials Comparison
This section allows you to compare key financial metrics between Tarsus Pharmaceuticals, Inc. and Apollo Global Management, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TARS vs. APO - Profitability Comparison
TARS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tarsus Pharmaceuticals, Inc. reported a gross profit of 73.12M and revenue of 78.34M. Therefore, the gross margin over that period was 93.4%.
APO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apollo Global Management, Inc. reported a gross profit of 5.22B and revenue of 5.55B. Therefore, the gross margin over that period was 94.1%.
TARS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tarsus Pharmaceuticals, Inc. reported an operating income of -26.28M and revenue of 78.34M, resulting in an operating margin of -33.6%.
APO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apollo Global Management, Inc. reported an operating income of 1.53B and revenue of 5.55B, resulting in an operating margin of 27.6%.
TARS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tarsus Pharmaceuticals, Inc. reported a net income of -25.12M and revenue of 78.34M, resulting in a net margin of -32.1%.
APO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apollo Global Management, Inc. reported a net income of 442.00M and revenue of 5.55B, resulting in a net margin of 8.0%.